BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
14 results:

  • 1. Chromosomal abnormalities and dysregulated DNA repair gene expression in farmers exposed to pesticides.
    Costa MB; Farias IR; da Silva Monte C; Filho LIPF; de Paula Borges D; de Oliveira RTG; Ribeiro-Junior HL; Magalhães SMM; Pinheiro RF
    Environ Toxicol Pharmacol; 2021 Feb; 82():103564. PubMed ID: 33326828
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure.
    Heidemann S; Bursic B; Zandi S; Li H; Abelson S; Klaassen RJ; Abish S; Rayar M; Breakey VR; Moshiri H; Dhanraj S; de Borja R; Shlien A; Dick JE; Dror Y
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31990679
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells.
    Li W; Liu W; Kakoki A; Wang R; Adebali O; Jiang Y; Sancar A
    J Biol Chem; 2019 Apr; 294(15):5914-5922. PubMed ID: 30808711
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome.
    Ribeiro HL; Maia ARS; de Oliveira RTG; Costa MB; Farias IR; de Paula Borges D; de Sousa JC; Magalhães SMM; Pinheiro RF
    J Clin Pathol; 2017 Nov; 70(11):970-980. PubMed ID: 28554891
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
    Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
    Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
    Sun Y; Wu Y; Li W; Kong Z; Zou X
    Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.
    Heimann SM; Vehreschild MJ; Cornely OA; Franke B; von Bergwelt-Baildon M; Wisplinghoff H; Kron F; Scheid C; Vehreschild JJ
    Eur J Haematol; 2015 Jun; 94(6):526-31. PubMed ID: 25310918
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of xpc gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
    Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
    Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
    Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
    Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
    Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
    Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RB stabilizes xpc and promotes cellular NER.
    Hardy TM; Kumar MS; Smith ML
    Anticancer Res; 2010 Jul; 30(7):2483-8. PubMed ID: 20682972
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The xpc gene markedly affects cell survival in mouse bone marrow.
    Fischer JL; Kumar MA; Day TW; Hardy TM; Hamilton S; Besch-Williford C; Safa AR; Pollok KE; Smith ML
    Mutagenesis; 2009 Jul; 24(4):309-16. PubMed ID: 19372135
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.
    Arlett CF; Plowman PN; Rogers PB; Parris CN; Abbaszadeh F; Green MH; McMillan TJ; Bush C; Foray N; Lehmann AR
    Br J Radiol; 2006 Jun; 79(942):510-7. PubMed ID: 16714754
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.